Efficacy of the four weeks treatment of omeprazole plus mosapride combination therapy compared with that of omeprazole monotherapy in patients with proton pump inhibitor-refractory gastroesophageal reflux disease: a randomized controlled trial
Source: Clinical and Experimental Gastroenterology - Category: Gastroenterology Tags: Clinical and Experimental Gastroenterology Source Type: research
More News: Acid Reflux | Gastroenterology | Gastroesophageal Reflux Disease | GERD | Omeprazole | Prilosec | Proton Pump Inhibitors PPIs